Johan Skog
- Cancer Research top 0.05%
- MicroRNA in disease regulation 17
- Cancer Genomics and Diagnostics 13
- Cancer-related molecular mechanisms research 9
- Molecular Biology top 0.2%
- Extracellular vesicles in disease 40
- RNA Interference and Gene Delivery 15
- Immunology and Allergy top 1%
- Immunology top 2%
- Genetics top 2%
-
- Prostate Cancer Diagnosis and Treatment 15
- Prostate Cancer Treatment and Research 11
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Xandra O. BreakefieldBob S. CarterAnna M. KrichevskySjoerd van RijnTom WürdingerDimphna H. MeijerWilliam T. CurryLeonora Balaj
- Journals
- Journal of Clinical Oncology (11 papers)Cancer Research (4 papers)Prostate Cancer and Prostatic Diseases (4 papers)
- Partner nations
- United StatesSwedenNetherlands
In The Last Decade
Johan Skog
84 papers receiving 14.5k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Cancer Research 8.8k
- Molecular Biology 12.7k
- Immunology and Allergy 612
- Immunology 1.2k
- Genetics 575
Countries citing papers authored by Johan Skog
This map shows the geographic impact of Johan Skog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Skog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Skog more than expected).
Fields of papers citing papers by Johan Skog
This network shows the impact of papers produced by Johan Skog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Skog. The network helps show where Johan Skog may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Johan Skog, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 33 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 29 | |
| 7 | 2021 | 66 | |
| 8 | 2020 | 35 | |
| 9 | 2019 | 0 | |
| 10 | 2018 | 171 | |
| 11 | 2018 | 76 | |
| 12 | 2018 | 55 | |
| 13 | 2015 | 305 | |
| 14 | 2014 | 1 | |
| 15 | 2014 | 1 | |
| 16 | 2014 | 14 | |
| 17 | 2013 | 161 | |
| 18 | 2012 | 127 | |
| 19 | 2008 | 352 | |
| 20 | 'SETTING' AND DURABILITY STUIDES ON PAVING GRADE ASPHALTS | 1967 | 0 |
About Johan Skog
Johan Skog is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Allergy and Transplantation, having authored 88 papers that have together received 14.7k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (40 papers), MicroRNA in disease regulation (17 papers), RNA Interference and Gene Delivery (15 papers), Prostate Cancer Diagnosis and Treatment (15 papers), Cancer Genomics and Diagnostics (13 papers), Prostate Cancer Treatment and Research (11 papers), Cancer-related molecular mechanisms research (9 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Cancer Research (8.8k citations), Molecular Biology (12.7k citations), Immunology and Allergy (612 citations), Immunology (1.2k citations) and Genetics (575 citations). Johan Skog has collaborated with scholars based in United States, Sweden and Netherlands. Frequent co-authors include Xandra O. Breakefield, Bob S. Carter, Anna M. Krichevsky, Sjoerd van Rijn, Tom Würdinger, Dimphna H. Meijer, William T. Curry, Leonora Balaj, Mikkel Noerholm and Fred H. Hochberg. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Prostate Cancer and Prostatic Diseases, Molecular Cancer Therapeutics and Journal of Extracellular Vesicles.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.